New antibiotics: epicillin, minocycline and spectinomycin a summary of their antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
D000081:Acetamides / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects; D003510:Cyclohexanes / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D004347:Drug Interactions; D006069:Gonorrhea / Q000188:drug therapy; D006207:Half-Life; D006801:Humans; D007700:Kinetics; D008589:Meningococcal Infections / Q000188:drug therapy; D008744:Methylamines; D008826:Microbial Sensitivity Tests; D010403:Penicillin Resistance; D010406:Penicillins / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D000198:Spectinomycin / Q000494:pharmacology / Q000627:therapeutic use; D013752:Tetracycline / Q000494:pharmacology / Q000627:therapeutic use
D000081:Acetamides; D003510:Cyclohexanes; D008744:Methylamines; D010406:Penicillins; D000198:Spectinomycin; D013752:Tetracycline